22/05/2013 - 10:30:00
Immunotherapeutic Cancer Drugs Ti...
Financial analysts have tipped the newly-emerging im...
Read More....22/05/2013 - 06:20:00
One in Ten Teenagers in the USA Usi...
According to a new study, one in ten US sophomore students are using prescr...
Read More....21/05/2013 - 05:55:00
Aspirin Prescription Algorithm Guid...
Newly-developed prescription algorithm gives doctors the tools to weigh up ...
Read More....20/05/2013 - 11:00:00
Three Quarters of Pharmacies Give P...
According to a new study, up to three quarters of pharmacies give poor medi...
Read More....16/05/2013 - 10:35:00
Opioid Drugs Linked to Erectile Dys...
Men who take high-dose opioid drugs for four months or more are 50 per cent...
Read More....Bowel Cancer Drug Trial Yields Promising Results
Posted by Paul Fiddian on 25/09/2007 - 23:57:51
The result of a new study may offer revitalised hope for patients with bowel cancer at an advanced stage. In recent research, it was observed that, when Avastin was taken in tandem with chemotherapy, cancers that had progressed to the liver...
Read more....Pfizer’s Oral HIV Drug Celsentri Approved for EU
Posted by Paul Fiddian on 24/09/2007 - 19:54:53
The dominant global pharmaceutical manufacturer, Pfizer, announced on the 24th September 2007 that European approval had been given for Celsentri — its orally-taken Aids drug. Having gained US approval in August, Celsentri is the first in a...
Read more....Infections Halt Merck HIV Vaccine Trial
Posted by Paul Fiddian on 24/09/2007 - 10:36:08
Merck, the prominent pharmaceutical firm, has ceased trialling a new HIV vaccine — thought of by many as having huge potential in the fight to destroy AIDs. The drug manufacturer ended the trials after the vaccine was deemed ineffective. Du...
Read more....Increasing Use of Generic Drugs Slows Prescription Prices
Posted by Paul Fiddian on 23/09/2007 - 20:47:26
While the cost of private health care in the US is on a constant climb, the price of prescription drugs is, perhaps surprisingly, increasing at a much slower rate. In actual fact, yearly increases in the cost of drugs are at their lowest si...
Read more....New Bill Strengthens US Regulator's Drug Safety Powers
Posted by Paul Fiddian on 22/09/2007 - 16:58:39
The US Congress has approved a radical overhaul of the US Food and Drug Administration's regulatory powers in an attempt to offer patients better protection from drugs once they enter the market. The legislation received full Senate approva...
Read more....China Considers New Drug Recall Measures
Posted by Paul Fiddian on 20/09/2007 - 18:03:15
Pharmaceutical International has today learnt of a radical new reform to China’s pharmaceutical sector — the implementation of which is currently being contemplated by the Chinese government. The essence of it is that Chinese drug manufactu...
Read more....US FDA Issues Initial Drug Safety Newsletter
Posted by Paul Fiddian on 20/09/2007 - 13:20:44
On the 18th September 2007, a new report was issued by the US Food and Drug Administration in which it highlighted the potential dangers of a number of drugs currently on the market. The report follows the ever-intensifying criticism levell...
Read more....Osteoporosis Drug Study Produces Reduced Death Rates
Posted by Paul Fiddian on 19/09/2007 - 13:57:30
A new study highlights the first recorded instance of a drug, designed for patients with osteoporosis, cutting rates of death and halting the development of new breaks in elderly people with broken hips. Certain industry experts have respon...
Read more....Doctors Failing to Discuss Drug-related Pregnancy Risks
Posted by Paul Fiddian on 18/09/2007 - 19:41:42
A new report has been issued which highlights the failure of doctors to properly warn female patients of the pregnancy-related risks associated with certain prescription drugs. The study was undertaken by the University of Pittsburgh Medica...
Read more....Two-Year-Long Study to Assess ADHD Drugs’ Heart Risk
Posted by Paul Fiddian on 18/09/2007 - 19:09:13
US officials confirmed on the 17th September 2007 that that the biggest ever investigation into the effects of drugs prescribed to patients with Attention Deficit Hyperactivity Disorder (ADHD) will soon commence. Spearheaded by two national...
Read more....